Caterina Ieranò

2.0k citations
34 papers · 1.4k indexed · h-index 20
Topics
Chemokine receptors and signaling (19 papers)Immunotherapy and Immune Responses (18 papers)Cancer Immunotherapy and Biomarkers (5 papers)

In The Last Decade

Caterina Ieranò

34 papers receiving 1.4k citations

Peers

Caterina Ieranò
Comparison fields: 5 of 83
  • Oncology 917
  • Molecular Biology 546
  • Immunology 462
  • Cancer Research 155
  • Pulmonary and Respiratory Medicine 119
Replace Pablo Matar with:
Pablo Matar Argentina
Jason E. Toombs United States
Julie Stockis Belgium
Turid Hellevik Norway
Emily Chu United States
Massimo Ammirante United States
Miriam Redrado Spain
Shu‐Fen Chiang Taiwan
Kousaku Mimura Japan
Alexandra Sevko Germany
Caterina Ieranò relative to Pablo Matar Argentina Pablo Matar's profile →
Citations per field
00.5×4.4×
Pablo Matar · 1×
Citations per year

Countries citing papers authored by Caterina Ieranò

Since Specialization
Citations

This map shows the geographic impact of Caterina Ieranò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caterina Ieranò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caterina Ieranò more than expected).

Fields of papers citing papers by Caterina Ieranò

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caterina Ieranò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caterina Ieranò. The network helps show where Caterina Ieranò may publish in the future.

Co-authorship network of co-authors of Caterina Ieranò

This figure shows the co-authorship network connecting the top 25 collaborators of Caterina Ieranò. A scholar is included among the top collaborators of Caterina Ieranò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caterina Ieranò. Caterina Ieranò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 70
3 54
4 17
5 81
6 12
7 39
8 19
9 72
10 88
11 43
12 74
13 76
14 11
15 23
16 32
17 64
18 2
19 12
20 32

About Caterina Ieranò

Caterina Ieranò is a scholar working on Oncology, Immunology and Hematology, having authored 34 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (19 papers), Immunotherapy and Immune Responses (18 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Oncology (917 citations), Immunology (462 citations) and Cancer Research (155 citations). Caterina Ieranò has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Stefania Scala, Robert W. Robey, Susan E. Bates, Akina Tamaki, Crescenzo D’Alterio, Gergely Szakács, Maria Napolitano, Anna Maria Trotta, Luigi Portella and Gerardo Botti. Their work appears in journals such as PLoS ONE, Biochemistry and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026